Across TCGA pan-cancer cohorts, TTTY3B RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated TTTY3B data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher TTTY3B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TTTY3B expression acts as an unfavorable survival marker.
THCA are the cancer types where TTTY3B RNA most reproducibly stratifies survival.